Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paola Maria Medusa
Observed names:
P.M. Medusa,
Paola Medusa
Institutions:
University of Campania "Luigi Vanvitelli",
Ospedale Monaldi
Observed institutions:
University of Campania "Luigi Vanvitelli",
Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli,
Ospedale Monaldi
ORCID:
0000-0003-0791-2240
Observed ORCID:
0000-0003-0791-2240
OpenAlex ID:
A5079522227
Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review
2022
·
Giuseppe Viscardi
, Fabiana Vitiello
, et al.
·
Cancers
·
8
PDF
Case report: Selpercatinib in the treatment of RET fusion-positive advanced lung adenocarcinoma: a challenging clinical case
2025
·
Raffaella Pagliaro
, Paola Maria Medusa
, et al.
·
Frontiers in Oncology
·
6
PDF
Effectiveness of Atezolizumab in Addition to Chemotherapy in ES-SCLC: A Retrospective Real-World Monocentric Study
2025
·
Raffaella Pagliaro
, Fabiana Vitiello
, et al.
·
Cancers
·
5
PDF
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort
2023
·
Pierantonio Grimaldi
, Antonio Russo
, et al.
·
Infection
·
5
PDF
Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report
2022
·
Paola Maria Medusa
, Marina Gilli
, et al.
·
Monaldi Archives for Chest Disease
·
5
PDF
Is Immunotherapy a Contraindication for Treating Lung Cancer Patients with Interstitial Lung Diseases? A Review of the Literature
2026
·
Raffaella Pagliaro
, Paola Della Monica
, et al.
·
Journal of Clinical Medicine
·
1
PDF
NK cell immune fitness stratifies small cell lung cancer into four functional states associated with clinical response
2026
·
Caterina De Rosa
, Fabio Somma
, et al.
·
The Journal of Liquid Biopsy
PDF
338eP Immunotherapy with or without chemotherapy for first line treatment of unresectable pleural mesothelioma (PM): A systematic review and meta-analysis
2026
·
G. Viscardi
, M. Brambilla
, et al.
·
ESMO Open
PDF
P3.18.18 Predictive Role of Respiratory Function Tests on Lung Toxicity in Stage III NSCLC Under Chemo-Radiotherapy and Durvalumab: Preludio Trial
2025
·
P.M. Medusa
, C.M. Della Corte
, et al.
·
Journal of Thoracic Oncology
A Retrospective Real-world Evaluation of Atezolizumab in Patient With Small Cell Lung Cancer (sclc): a Monocentric Study
2025
·
Raffaella Pagliaro
, Antonio D'Orologio
, et al.
·
European Respiratory Journal
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIAL
2025
·
P.M. Medusa
, N. Carro
, et al.
·
Lung Cancer
Show more works
View as search
Works count:
11
Citation count:
30
H-index:
5
I10-index:
Year
Topic
Type